Drug Trial Radar · NCT00855855
Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Last checked: Nov 19, 2026Latest source record: Apr 25, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20,830
Actual
Start
Feb 2009
Primary completion
Dec 2014
Study completion Dec 2014
Sponsor
- Lead sponsor
- Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
- Sponsor type
- Industry
- First posted
- Mar 4, 2009
Design
- Study type
- Observational
- Who can join
- All sexes, up to 59 months
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To monitor the occurrence of invasive Hib disease over time and to determine product-specific rates of invasive Hib disease within the monitored population.
Conditions
- Haemophilus Infections
- Diphtheria
- Tetanus
- Polio
- Pertussis
Interventions
DTaP-IPV/HibBiological
0.5 mL, Intramuscular
Primary outcomes
What the sponsor says the trial is designed to measure.
- The rate of invasive Hib disease among persons within the population monitored by the Active Bacterial Core surveillance program.Time frame: Up to 6 years post vaccination
Locations
59 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Albany, California
Site not named
Martinez, California
Site not named
San Francisco, California
Site not named
Applewood, Colorado
Site not named
Aurora, Colorado
Site not named
Brighton, Colorado
Site not named
Castle Rock, Colorado
Site not named
Denver, Colorado
Site not named
Hartford, Connecticut
Site not named
Adamsville, Georgia
Site not named
Auburn, Georgia
Site not named
Canton, Georgia
Site not named
Carrollton, Georgia
Site not named
Cartersville, Georgia
Site not named
Conyers, Georgia
Site not named
Covington, Georgia
Site not named
Cumming, Georgia
Site not named
Dallas, Georgia
Site not named
Decatur, Georgia
Site not named
Douglasville, Georgia
Site not named
Fayetteville, Georgia
Site not named
Good Hope, Georgia
Site not named
Griffin, Georgia
Site not named
Hampton, Georgia
Site not named
Jasper, Georgia
Site not named
Jonesboro, Georgia
Site not named
Marietta, Georgia
Site not named
Newnan, Georgia
Site not named
Annapolis, Maryland
Site not named
Saint Paul, Minnesota
Site not named
Santa Fe, New Mexico
Site not named
Albany, New York
Site not named
Amsterdam, New York
Site not named
Avon, New York
Site not named
Batavia, New York
Site not named
Bellona, New York
Site not named
Canandaigua, New York
Site not named
Catskill, New York
Site not named
Chatham, New York
Site not named
Geneva, New York
Showing 40 of 59 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.